insights_auto
Kāpēc uzņēmuma AMGN34 akciju cena ir pieaugusi 2,58%?
Atklājiet vairāk iespējuchevron_right
AMGN34:BVMF
Amgen Inc. BDR
81,04 R$
arrow_upward
+2,58%(+2,04) 1 d.
22. okt., 16:56:00 GMT-3 · BRL
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: AMGN34…
Atvērt
79,00 R$
Augsta
81,04 R$
Zema
79,00 R$
Tirgus kapitalizācija
241,81 mljrd.
Vid. apjoms
425,00
Apjoms
712,00
Augstākā 52 ned.
83,06 R$
Zemākā 52 ned.
47,76 R$
Apgrozībā esošās akcijas
540,63 milj.
Darbinieku skaits
32 tūkst.
Atvērt
79,00 R$
Augsta
81,04 R$
Zema
79,00 R$
Tirgus kapitalizācija
241,81 mljrd.
Vid. apjoms
425,00
Apjoms
712,00
Augstākā 52 ned.
83,06 R$
Zemākā 52 ned.
47,76 R$
Apgrozībā esošās akcijas
540,63 milj.
Darbinieku skaits
32 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Yahoo Finance
·
pirms 3 stundām
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Yahoo Finance
·
pirms 5 stundām
Amgen (AMGN) Gains As Market Dips: What You Should Know
Investor's Business Daily
·
pirms 5 stundām
Tech Stocks Hit, Yields Plunge As AI Trade Fizzles: NetApp, Amgen, Nasdaq In Focus
Investing.com
·
pirms 11 stundām
Amgen stock hits all-time high at 447.09 USD
Profils
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Par “Amgen Inc. BDR”
ĢenerāldirektorsRobert A. Bradway
Darbinieki31,5 tūkst.
Dibināšanas datums1980
Galvenais birojsTauzandoksa, Kalifornija, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneamgen.com